Indigestion Completed Phase 3 Trials for Cinitapride (DB08810)

Also known as: Dyspepsia

IndicationStatusPhase
DBCOND0031004 (Indigestion)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01355276Efficacy and Safety of Cinitapride Tablets in the Treatment of Mild to Moderate Functional DyspepsiaTreatment